Research and Markets: Global Glomerulonephritis Pipeline Report 2015 - 12 Companies & 13 Drug Profiles
Research and Markets: Global Ischemic Stroke Pipeline Report 2015
Biogen Announces $5 Billion Share Repurchase Program
UPDATE: 5 charts that show stock buybacks are rapidly losing their luster
Ignyta Announces First Quarter 2015 Company Highlights and Financial Results
Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO
All investments involve risk, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. The information provided in this posting is not a complete analysis of every material fact regarding any country, region, ...
Success starts with teamwork for this year's winners.